Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to $131583.0.

  • Cumberland Pharmaceuticals' Interest & Investment Income rose 9017.63% to $131583.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $491448.0, marking a year-over-year increase of 5915.95%. This contributed to the annual value of $334444.0 for FY2024, which is 1659.03% up from last year.
  • Latest data reveals that Cumberland Pharmaceuticals reported Interest & Investment Income of $131583.0 as of Q3 2025, which was up 9017.63% from $127489.0 recorded in Q2 2025.
  • In the past 5 years, Cumberland Pharmaceuticals' Interest & Investment Income registered a high of $131583.0 during Q3 2025, and its lowest value of $5426.0 during Q1 2021.
  • Over the past 5 years, Cumberland Pharmaceuticals' median Interest & Investment Income value was $57061.0 (recorded in 2023), while the average stood at $59503.4.
  • In the last 5 years, Cumberland Pharmaceuticals' Interest & Investment Income plummeted by 8184.56% in 2021 and then surged by 58509.75% in 2022.
  • Cumberland Pharmaceuticals' Interest & Investment Income (Quarter) stood at $6670.0 in 2021, then soared by 585.1% to $45696.0 in 2022, then soared by 77.26% to $81000.0 in 2023, then skyrocketed by 31.69% to $106667.0 in 2024, then rose by 23.36% to $131583.0 in 2025.
  • Its last three reported values are $131583.0 in Q3 2025, $127489.0 for Q2 2025, and $125709.0 during Q1 2025.